| Bioactivity | Lintopride is a 5HT4 antagonist with moderate 5HT3 antagonist properties. | ||||||||||||
| Invitro | Lintopride significantly increases the lower oesophageal sphincter basal tone without affecting lower oesophageal sphincter physiological relaxation after swallowing. Peristaltic waves are also enhanced by Lintopride[1]. | ||||||||||||
| Name | Lintopride | ||||||||||||
| CAS | 107429-63-0 | ||||||||||||
| Formula | C14H19ClN4O2 | ||||||||||||
| Molar Mass | 310.78 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Delvaux M, et al. The effects of lintopride, a 5HT-4 antagonist, on oesophageal motility. Aliment Pharmacol Ther. 1995 Oct;9(5):563-9. |